Teva Pharmaceutical Industries Limited (TLV:TEVA)

Market Cap	124.25B +79.6%
Revenue (ttm)	55.02B +4.3%
Net Income	4.50B
EPS	3.86
Shares Out	n/a
PE Ratio	27.64
Forward PE	12.68
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,316,825
Average Volume	1,907,172
Open	10,720
Previous Close	10,640
Day's Range	10,650 - 10,820
52-Week Range	4,865 - 11,350
Beta	0.72
RSI	58.02
Earnings Date	Jan 28, 2026

About TLV:TEVA

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products with medical devices and combination products. The com...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1901
• Employees: 32,842
• Stock Exchange: Tel Aviv Stock Exchange
• Ticker Symbol: TEVA

Financial Performance

Financial numbers in USD